#EANO2024 Congratulations to Alberto Picca for receiving the EANO Young Investigator Travel Scholarship! Join him at the Keynote Session: Gliomas with pleomorphic & pseudopapillary features […]
📅 SUN, Oct 20 🕙 10:10-10:20 📍 Lomond Auditorium
💡Have you heard? Our #EducationalDay is taking place in conjunction with #EANO2024 on October 17.
👉Check out the programme and register! We look forward to meeting you in Glasgow! https://t.co/3LNcNhaUT9
#btsm#braintumors#cancer#glasgow
🎙 [CALL FOR ABSTRACTS]
You are a young researcher (PhD, Post-doc) working on brain tumor microenvironment ? Oral communications and posters sessions are planned to allow you to present your work to an international panel of experts!
👉 Details here: https://t.co/otD1VZRwxZ
📢 [Nouvelle publication] : résultats d'un essai thérapeutique explorant l’efficacité du traitement par fexagratinib dans un sous-type de gliome diffus
👉Pour en savoir plus : https://t.co/4IUYGIWSwg
@alberto_picca
📢 Just published in JCO! What is the optimal chemotherapy for oligodendroglioma patients? Our study using data from the national prospective cohort POLA found better PFS and OS outcomes with first-line RT/PCV compared to RT/TMZ https://t.co/gpo18OHnt8
📢 [OPEN REGISTRATIONS & CALL FOR ABSTRATCS] - Brain Tumor Microenvironment Symposium - 30th & 31st January 2025 - Paris
The SiRIC CURAMUS is delighted to organize its very first Brain Tumor Microenvironment Symposium !
👉 Program and registrations: https://t.co/otD1VZQYIr
Happy to share our preprint! A big thank you to all the collaborators, co-authors, and everyone involved in this study. Feel free to contact us to discuss our findings; your scientific feedback is more than welcome. https://t.co/LkM1NJbA19
📢 Only a few days left to register for the Oligodendroglioma Workshop that will take place the 20 & 21 september 2024 at the @InstitutCerveau in Paris, to mark the 15th anniversary of the POLA rare cancer network !
👇
https://t.co/JnjrLftyNn
🔥Publication🔥
High impact publication from the Marie Lab
#support from the SIRIC of Lyon, LYriCAN+
@julienCMarie1 (WP leader / IRP1 of the LYriCAN+) describes data that strongly challenges the role of immune cells in the initiation of cancer.
@crcl@InsermAuRA@CLCCLeonBerard
📢#Prix 2024 du @canceropole avec le soutien de la @FondationARC
🏅#Doctorants et #Postdoctorants franciliens, soyez récompensé pour vos travaux dans le domaine du cancer et présentez votre travail lors de notre 17e Colloque
📅Date limite : 9/09/2024
🔗https://t.co/ihMgx5sJcp
📢 #AAP Emergence 2025-1
📑 Financements de projets dans le domaine du cancer sur le thème "Nouveaux modèles précliniques et organoïdes". Toutes les disciplines sont éligibles, y compris SHS-E-SP !
💰40k€ sur 1 an.
📅 Date limite : 15/10/2024, midi
🔗 https://t.co/25Uh1rBRmP
📢 Don't miss the Oligodendroglioma Workshop the 20 & 21 september 2024 at the @InstitutCerveau in Paris !
📌 This workshop is being organised to mark the 15th anniversary of the POLA rare cancer network.
👉 Program and registration: https://t.co/JnjrLft0XP
👏 Félicitations au Pr Frédéric Davi de la #PitiéSalpêtrière, lauréat du trophée Brevet Prometteur pour sa méthode pour la détermination du statut mutationnel des gènes des chaînes lourdes des immunoglobines dans la leucémie lymphoïde chronique ! @APHP
https://t.co/r5ly5W0rX1